OPEN END TURBO PUT WARRANT - ELI LILLY & CO | Market Closed - Boerse Frankfurt Warrants 13:30:34 2024-05-31 EDT | ||
| 25.33 EUR | +1.04% |
|
| Current month | -12.93% | ||
| 1 month | -12.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 25.33 | +1.04% |
| 24-05-30 | 25.07 | -3.58% |
| 24-05-29 | 26 | -0.73% |
| 24-05-28 | 26.19 | +3.03% |
| 24-05-27 | 25.42 | -1.82% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 01:30 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | UBS |
| WKN | UM2DZD |
| ISIN | DE000UM2DZD0 |
| Date issued | 2024-02-07 |
| Strike | 1,088 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 35.81 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 35.67 € |
|---|---|
| Lowest since issue | 24.31 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
820.3
USD
Average target price
852.5
USD
Spread / Average Target
+3.92%
- Stock Market
- Certificates
- Certificat
